Metabolic Signaling in the Tumor Microenvironment

Area of Science:

• Oncology
• Cancer Metabolism
• Immunology

Background:

• Cancer cells reprogram metabolism, utilizing aerobic glycolysis and alternative carbon sources.
• This metabolic shift supports rapid growth but generates byproducts, creating a hostile tumor microenvironment (TME) with low pH and redox stress.
• Research increasingly focuses on how the tumor's metabolic landscape influences the anti-tumor immune response.

Purpose of the Study:

• To review how metabolic reprogramming in cancer cells contributes to tumorigenesis.
• To explore the role of secreted metabolites in the TME and their crosstalk between different cell types.
• To examine the impact of resource competition and metabolic crosstalk on immune cell function.

Main Methods:

• Literature review of cancer metabolism and tumor microenvironment interactions.
• Analysis of metabolic pathways utilized by cancer, immune, and stromal cells.
• Investigation of metabolite secretion and its effects on cellular crosstalk.

Main Results:

• Metabolic reprogramming in cancer cells fuels growth but creates a hostile TME.
• Secreted metabolites within the TME mediate crosstalk, promoting tumorigenesis.
• Metabolic competition and crosstalk significantly hinder anti-tumor immune responses.

Conclusions:

• Metabolic crosstalk between cancer, immune, and stromal cells is a critical driver of tumorigenesis.
• Understanding these metabolic interactions is crucial for developing novel cancer therapies.
• Targeting metabolic pathways and TME crosstalk may enhance anti-tumor immunity.